Niels Svenstrup
Corporate Officer/Principal bei PEPGEN INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Niels Svenstrup
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PEPGEN INC. | Corporate Officer/Principal | 01.04.2021 | - |
Karriereverlauf von Niels Svenstrup
Ehemalige bekannte Positionen von Niels Svenstrup
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.07.2017 | 01.04.2021 |
ASCENDIS PHARMA A/S | Corporate Officer/Principal | 01.11.2015 | 01.07.2017 |
H. LUNDBECK A/S | Corporate Officer/Principal | 01.05.2008 | 01.11.2015 |
Ausbildung von Niels Svenstrup
University of Southern Denmark | Doctorate Degree |
Statistik
International
Dänemark | 4 |
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PEPGEN INC. | Health Technology |
ASCENDIS PHARMA A/S | Health Technology |
H. LUNDBECK A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Niels Svenstrup
- Erfahrung